Bo Wu
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 24
-
- RNA Interference and Gene Delivery 10
- Co-authors
- Lingyun Wu (8 shared papers)Shi‐Wen Huang (21 shared papers)Rui Wang (8 shared papers)Guangdong Yang (5 shared papers)Ren‐Xi Zhuo (13 shared papers)Huajian Teng (3 shared papers)Haibo Xu (11 shared papers)Caixia Wang (3 shared papers)
- Journals
- Biomaterials (6 papers)Journal of Controlled Release (4 papers)Biomaterials Science (4 papers)Cell & Bioscience (3 papers)International Journal of Nanomedicine (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bo Wu
114 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 126
- Biochemistry 496
- Biomaterials 507
- Biomedical Engineering 858
- Endocrine and Autonomic Systems 104
- Immunology 264
Countries citing papers authored by Bo Wu
This map shows the geographic impact of Bo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wu more than expected).
Fields of papers citing papers by Bo Wu
This network shows the impact of papers produced by Bo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wu. The network helps show where Bo Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 193 | |
| 2 | 2013 | 182 | |
| 3 | 2021 | 125 | |
| 4 | 2020 | 122 | |
| 5 | 2017 | 106 | |
| 6 | 2020 | 79 | |
| 7 | 2011 | 72 | |
| 8 | 2017 | 69 | |
| 9 | 2007 | 63 | |
| 10 | 2006 | 62 | |
| 11 | 2007 | 60 | |
| 12 | 2017 | 59 | |
| 13 | 2012 | 59 | |
| 14 | 2015 | 54 | |
| 15 | 2015 | 52 | |
| 16 | 2007 | 50 | |
| 17 | 2020 | 49 | |
| 18 | 2016 | 45 | |
| 19 | 2019 | 43 | |
| 20 | 2020 | 38 |
About Bo Wu
Bo Wu is a scholar working on Biomedical Engineering, Molecular Biology, Biomaterials, Materials Chemistry and Biochemistry, having authored 120 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (18 papers), Sulfur Compounds in Biology (13 papers), RNA Interference and Gene Delivery (10 papers), Tuberculosis Research and Epidemiology (6 papers), Immunotherapy and Immune Responses (5 papers), Molecular Sensors and Ion Detection (5 papers) and Lanthanide and Transition Metal Complexes (4 papers). The work is most often cited by research in Biochemistry (496 citations), Biomaterials (507 citations), Biomedical Engineering (858 citations), Endocrine and Autonomic Systems (104 citations) and Immunology (264 citations). Bo Wu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lingyun Wu, Shi‐Wen Huang, Rui Wang, Guangdong Yang, Ren‐Xi Zhuo, Huajian Teng, Haibo Xu, Caixia Wang, Shuting Lu and Zhihong Liu. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Biomaterials Science, Cell & Bioscience and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.